PHMlogo2015
PHM Focus

Schedule at a Glance

Neonatal Abstinence Syndrome - It's Not Just for Neonatologists Anymore!

Primary Leader:
Rebecca Dixon

Co-Leaders:
Emily Scott
Patrick Clemments

Objective 1:
Recognize the rapidly growing problem of Neonatal Abstinence Syndrome and its impact on healthcare.

Objective 2:
Learn to employ a consistent screening and scoring system to identify infants at risk for withdrawal.

Objective 3:
Identify promising/best practices for treatment and follow-up of infants with NAS.

Summary:
Neonatal Abstinence Syndrome (NAS) - a drug withdrawal syndrome that presents in the first days of a newborn's life as a result of maternal narcotic use during pregnancy - has become an epidemic. As drug use (both prescribed and illicit) has risen, so has the incidence of NAS and its far-reaching effects. Historically, NAS was treated by neonatologists in tertiary care settings. However, as opioid use in communities increases, NAS is now a problem encountered by pediatricians and hospitalists providing newborn care. In this presentation, we will review methods for identifying infants at risk for NAS, the scoring systems used to guide the initiation of therapy, and the best practices for treatment - including behavioral, environmental, and pharmacologic therapies. We will also explore areas for prevention and advocacy in the community and beyond. An audience response system will be used during the presentation for an interactive an enlightening experience.